Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Vasoactive Agents for Adult Septic Shock: An Update and Review.

Dalimonte MA, DeGrado JR, Anger KE.

J Pharm Pract. 2019 May 5:897190019844124. doi: 10.1177/0897190019844124. [Epub ahead of print]

PMID:
31057085
2.

"Inactive" ingredients in oral medications.

Reker D, Blum SM, Steiger C, Anger KE, Sommer JM, Fanikos J, Traverso G.

Sci Transl Med. 2019 Mar 13;11(483). pii: eaau6753. doi: 10.1126/scitranslmed.aau6753. Review.

PMID:
30867323
3.

Evaluation of sedatives, analgesics, and neuromuscular blocking agents in adults receiving extracorporeal membrane oxygenation.

DeGrado JR, Hohlfelder B, Ritchie BM, Anger KE, Reardon DP, Weinhouse GL.

J Crit Care. 2017 Feb;37:1-6. doi: 10.1016/j.jcrc.2016.07.020. Epub 2016 Aug 10.

PMID:
27610584
4.

The Effect of Concomitant Sirolimus and Propofol Therapy on Triglyceride Concentrations in Critically Ill Patients.

Dube KM, Szumita PM, Rocchio MA, Lee PS, Anger KE.

Am J Ther. 2019 Jan/Feb;26(1):e103-e109. doi: 10.1097/MJT.0000000000000461.

PMID:
27340909
5.

Clinical and Economic Impact of Formulary Conversion From Inhaled Flolan to Inhaled Veletri for Refractory Hypoxemia in Critically Ill Patients.

Torbic H, Szumita PM, Anger KE, Nuccio P, Lagambina S, Weinhouse G.

Ann Pharmacother. 2016 Feb;50(2):106-12. doi: 10.1177/1060028015621308. Epub 2015 Dec 14.

PMID:
26668204
6.

Prospective evaluation of inappropriate unable-to-assess CAM-ICU documentations of critically ill adult patients.

Terry KJ, Anger KE, Szumita PM.

J Intensive Care. 2015 Nov 26;3:52. doi: 10.1186/s40560-015-0119-y. eCollection 2015.

7.

Utilization of a Pharmacy Clinical Surveillance System for Pharmacist Alerting and Communication at a Tertiary Academic Medical Center.

Hohlfelder B, Stashek C, Anger KE, Szumita PM.

J Med Syst. 2016 Jan;40(1):24. doi: 10.1007/s10916-015-0398-9. Epub 2015 Nov 7.

PMID:
26547844
8.

Pathophysiology, assessment, and management of pain in critically ill adults.

Reardon DP, Anger KE, Szumita PM.

Am J Health Syst Pharm. 2015 Sep 15;72(18):1531-43. doi: 10.2146/ajhp140541. Review.

PMID:
26346209
9.

Etanercept for the Treatment of Transplantation-Related Lung Injury After Hematopoietic Stem Cell Transplantation.

Hohlfelder BA, Anger KE, Szumita PM, Degrado JR.

Am J Ther. 2017 Jul/Aug;24(4):e386-e392. doi: 10.1097/MJT.0000000000000315.

PMID:
26280291
10.

Enhanced responsibilities for pharmacy interns at a teaching hospital.

Gillis CM, Anger KE, Cotugno MC.

J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):198-202. doi: 10.1331/JAPhA.2015.14022.

PMID:
25699989
11.

Evaluation of glucose management during therapeutic hypothermia at a Tertiary Academic Medical Center.

Forni AA, Rocchio MA, Szumita PM, Anger KE, Avery KR, Scirica BM.

Resuscitation. 2015 Apr;89:64-9. doi: 10.1016/j.resuscitation.2015.01.002. Epub 2015 Jan 17.

PMID:
25600182
12.

Inpatient pharmacological sleep aid utilization is common at a tertiary medical center.

Gillis CM, Poyant JO, Degrado JR, Ye L, Anger KE, Owens RL.

J Hosp Med. 2014 Oct;9(10):652-7. doi: 10.1002/jhm.2246. Epub 2014 Aug 6.

PMID:
25130534
13.

Early vasopressin reduces incidence of new onset arrhythmias.

Reardon DP, DeGrado JR, Anger KE, Szumita PM.

J Crit Care. 2014 Aug;29(4):482-5. doi: 10.1016/j.jcrc.2014.03.005. Epub 2014 Mar 22.

PMID:
24747036
14.

Safety of compounded calcium chloride admixtures for peripheral intravenous administration in the setting of a calcium gluconate shortage.

Anger KE, Belisle C, Colwell MB, Dannemiller R, Alawadhi B, Wilkocki A, Szumita PM.

J Pharm Pract. 2014 Oct;27(5):474-7. doi: 10.1177/0897190013513617. Epub 2013 Dec 10.

PMID:
24326409
15.

Evaluation of an institution-wide guideline for hyperglycemic emergencies at a tertiary academic medical center.

Beik N, Anger KE, Forni AA, Bawa K, Szumita PM.

Ann Pharmacother. 2013 Oct;47(10):1260-5. doi: 10.1177/1060028013503111.

PMID:
24259689
16.

Antiepileptics for seizure prophylaxis after traumatic brain injury.

Torbic H, Forni AA, Anger KE, Degrado JR, Greenwood BC.

Am J Health Syst Pharm. 2013 Dec 1;70(23):2064, 2067. doi: 10.2146/ajhp130439. No abstract available.

PMID:
24249751
17.

Impact of an immunoglobulin G-specific enzyme-linked immunosorbent assay on the management of heparin-induced thrombocytopenia.

Sylvester KW, Fanikos J, Anger KE, Matta L, Southard RA, Beik N, Lemire SJ, Dorfman DM, Berliner N.

Pharmacotherapy. 2013 Nov;33(11):1191-8. doi: 10.1002/phar.1322. Epub 2013 Jun 27.

PMID:
23813781
18.

Evaluation of recombinant activated protein C for severe sepsis at a tertiary academic medical center.

Anger KE, Degrado JR, Greenwood BC, Cohen SA, Szumita PM.

Ther Clin Risk Manag. 2013;9:277-84. doi: 10.2147/TCRM.S45412. Epub 2013 Jun 5.

19.

Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients.

Torbic H, Szumita PM, Anger KE, Nuccio P, LaGambina S, Weinhouse G.

J Crit Care. 2013 Oct;28(5):844-8. doi: 10.1016/j.jcrc.2013.03.006. Epub 2013 May 14.

PMID:
23683572
20.

Role of dexmedetomidine in adults in the intensive care unit: an update.

Reardon DP, Anger KE, Adams CD, Szumita PM.

Am J Health Syst Pharm. 2013 May 1;70(9):767-77. doi: 10.2146/ajhp120211. Review.

PMID:
23592359
21.

Use of antiepileptics for seizure prophylaxis after traumatic brain injury.

Torbic H, Forni AA, Anger KE, Degrado JR, Greenwood BC.

Am J Health Syst Pharm. 2013 May 1;70(9):759-66. doi: 10.2146/ajhp120203. Review.

PMID:
23592358
22.
23.

Implementation of a journal surveillance program.

Anger KE, Szumita PM.

Am J Health Syst Pharm. 2012 Feb 1;69(3):194, 196-7. doi: 10.2146/ajhp110103. No abstract available.

PMID:
22261940
24.

Evaluation of a local ICU sedation guideline on goal-directed administration of sedatives and analgesics.

Degrado JR, Anger KE, Szumita PM, Pierce CD, Massaro AF.

J Pain Res. 2011;4:127-34. doi: 10.2147/JPR.S18161. Epub 2011 May 2.

25.

Evaluation of dexmedetomidine versus propofol-based sedation therapy in mechanically ventilated cardiac surgery patients at a tertiary academic medical center.

Anger KE, Szumita PM, Baroletti SA, Labreche MJ, Fanikos J.

Crit Pathw Cardiol. 2010 Dec;9(4):221-6. doi: 10.1097/HPC.0b013e3181f4ec4a.

PMID:
21119342
26.

Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study.

Roberts RJ, Barletta JF, Fong JJ, Schumaker G, Kuper PJ, Papadopoulos S, Yogaratnam D, Kendall E, Xamplas R, Gerlach AT, Szumita PM, Anger KE, Arpino PA, Voils SA, Grgurich P, Ruthazer R, Devlin JW.

Crit Care. 2009;13(5):R169. doi: 10.1186/cc8145. Epub 2009 Oct 29.

27.

Sedation and analgesia in the intensive care unit: evaluating the role of dexmedetomidine.

Szumita PM, Baroletti SA, Anger KE, Wechsler ME.

Am J Health Syst Pharm. 2007 Jan 1;64(1):37-44. Review.

PMID:
17189578
28.

Barriers to glucose control in the intensive care unit.

Anger KE, Szumita PM.

Pharmacotherapy. 2006 Feb;26(2):214-28. Review.

PMID:
16466326

Supplemental Content

Loading ...
Support Center